4//SEC Filing
Kalkstein Robert L 4
Accession 0001213900-19-003447
CIK 0000948320other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:03 AM ET
Size
8.2 KB
Accession
0001213900-19-003447
Insider Transaction Report
Form 4
Kalkstein Robert L
Chief Financial Officer
Transactions
- Other
Options to purchase Common Stock
2017-10-01$0.28/sh+150,000$42,000→ 150,000 totalExercise: $0.28From: 2017-10-01Exp: 2027-09-30→ Common Stock (150,000 underlying) - Other
Options to purchase Common Stock
2019-03-01$0.28/sh+150,000$42,000→ 150,000 totalExercise: $0.28From: 2019-03-31Exp: 2027-09-30→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]These options were previously reported by Mr. Kalkstein on his Form 3 filed with the Commission on November 13, 2017. Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28.
- [F2]Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28 and now vest on March 31, 2019. Additionally, the 200,000 to be issued to Mr. Kalkstein pursuant to his consulting agreement were cancelled and Mr. Kalkstein also has forgone $32,500 owed to him by Conversion Labs, Inc.
Documents
Issuer
CONVERSION LABS, INC.
CIK 0000948320
Entity typeother
Related Parties
1- filerCIK 0001526136
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:03 AM ET
- Size
- 8.2 KB